
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effects of sacubitril‐valsartan in the treatment of chronic heart failure patients with end‐stage renal disease undergoing dialysis
Xiaoyan Liu, Lidong Huang, Gary Tse, et al.
Clinical Cardiology (2023) Vol. 46, Iss. 8, pp. 930-936
Open Access | Times Cited: 11
Xiaoyan Liu, Lidong Huang, Gary Tse, et al.
Clinical Cardiology (2023) Vol. 46, Iss. 8, pp. 930-936
Open Access | Times Cited: 11
Showing 11 citing articles:
Efficacy and safety of angiotensin receptor–neprilysin inhibition in heart failure patients with end‐stage kidney disease on maintenance dialysis: A systematic review and meta‐analysis
Nguyễn Việt Dũng, Thanh Ngoc Le, Binh Quang Truong, et al.
European Journal of Heart Failure (2024)
Open Access | Times Cited: 8
Nguyễn Việt Dũng, Thanh Ngoc Le, Binh Quang Truong, et al.
European Journal of Heart Failure (2024)
Open Access | Times Cited: 8
Angiotensin Receptor Blocker-Neprilysin Inhibitor for Heart Failure with Reduced Ejection Fraction
Dima Nasrallah, Alaa Abdelhamid, Omar Tluli, et al.
Pharmacological Research (2024) Vol. 204, pp. 107210-107210
Open Access | Times Cited: 4
Dima Nasrallah, Alaa Abdelhamid, Omar Tluli, et al.
Pharmacological Research (2024) Vol. 204, pp. 107210-107210
Open Access | Times Cited: 4
Efficacy and safety of sacubitril-valsartan in hypertension patients with end-stage kidney disease on maintenance dialysis: a meta-analysis
Nguyễn Việt Dũng, Giang Thai Pham, Son Pham, et al.
Journal of Hypertension (2025)
Closed Access
Nguyễn Việt Dũng, Giang Thai Pham, Son Pham, et al.
Journal of Hypertension (2025)
Closed Access
The association of vascular access flow with sacubitril/valsartan and left ventricular ejection fraction in hemodialysis patients with heart failure with reduced ejection fraction
Fan-Yu Chen, Ann Charis Tan, Chyong‐Mei Chen, et al.
Clinical Kidney Journal (2025) Vol. 18, Iss. 4
Open Access
Fan-Yu Chen, Ann Charis Tan, Chyong‐Mei Chen, et al.
Clinical Kidney Journal (2025) Vol. 18, Iss. 4
Open Access
Sacubitril-Valsartan in Patients Requiring Hemodialysis
Dustin Le, Morgan E. Grams, Josef Coresh, et al.
JAMA Network Open (2024) Vol. 7, Iss. 8, pp. e2429237-e2429237
Open Access | Times Cited: 3
Dustin Le, Morgan E. Grams, Josef Coresh, et al.
JAMA Network Open (2024) Vol. 7, Iss. 8, pp. e2429237-e2429237
Open Access | Times Cited: 3
Benefits of sacubitril/valsartan administration and physical training in cardiac rehabilitation: current trends and bibliometric analysis of the years 2015-2024
Diana Carina Iovanovici, Bombonica Gabriela Dogaru, Carmen Delia Nistor-Cseppento, et al.
Balneo and PRM Research Journal (2024) Vol. 15, Iss. Vol.15, no. 2, pp. 683-683
Open Access | Times Cited: 2
Diana Carina Iovanovici, Bombonica Gabriela Dogaru, Carmen Delia Nistor-Cseppento, et al.
Balneo and PRM Research Journal (2024) Vol. 15, Iss. Vol.15, no. 2, pp. 683-683
Open Access | Times Cited: 2
Role of angiotensin receptor-neprilysin inhibitor in diabetic complications
Ying Liu, Cun-Yu Lu, Yi Zheng, et al.
World Journal of Diabetes (2024) Vol. 15, Iss. 5, pp. 867-875
Open Access | Times Cited: 1
Ying Liu, Cun-Yu Lu, Yi Zheng, et al.
World Journal of Diabetes (2024) Vol. 15, Iss. 5, pp. 867-875
Open Access | Times Cited: 1
Angiotensin Receptor-Neprilysin Inhibitor for Chronic Kidney Disease: Strategies for Renal Protection
Erika Hishida, Daisuke Nagata
Kidney & Blood Pressure Research (2024) Vol. 49, Iss. 1, pp. 916-932
Open Access
Erika Hishida, Daisuke Nagata
Kidney & Blood Pressure Research (2024) Vol. 49, Iss. 1, pp. 916-932
Open Access
Angiotensin Receptor–Neprilysin Inhibitor in Heart Failure Patients With Renal Dysfunction
Xiaogang Zhu, Xialing Li, Lingxuan Zhu, et al.
Cardiovascular Therapeutics (2024) Vol. 2024, Iss. 1
Open Access
Xiaogang Zhu, Xialing Li, Lingxuan Zhu, et al.
Cardiovascular Therapeutics (2024) Vol. 2024, Iss. 1
Open Access
The impact of angiotensin-receptor neprilysin inhibitors on cardiovascular events and solute transport function in peritoneal dialysis patients: a multicenter retrospective controlled study
Yishu Wang, Canxin Zhou, Xiaoyan Ma, et al.
Renal Failure (2024) Vol. 46, Iss. 2
Open Access
Yishu Wang, Canxin Zhou, Xiaoyan Ma, et al.
Renal Failure (2024) Vol. 46, Iss. 2
Open Access